Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Stock Quote Today & Recent News Soligenix Inc SNGX

Healthcare Biotechnology
Soligenix, Inc. is a late-stage biopharmaceutical company focused on developing and commercializing products to treat rare diseases where there is an unmet medical need. Its Specialized BioTherapeutics segment is developing and focused on the commercialization of HyBryte (a proposed name of SGX301), a novel photodynamic therapy (PDT), utilizing topical synthetic hypericin activated with safe... see more
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >

Current News (NDAQ:SNGX)

Soligenix Announces Pricing of $4.75 Million Public Offering

PR Newswire 5 days ago

FDA Grants Soligenix Orphan Drug Designation for the Prevention and Post-Exposure Prophylaxis Against Marburg Marburgvirus Infection

PR Newswire 8 days ago

FDA Grants Soligenix Orphan Drug Designation for the Prevention and Post-Exposure Prophylaxis Against Sudan Ebolavirus Infection

PR Newswire 12 days ago

Soligenix Announces Agreement on the Design of a Second Confirmatory Placebo-Controlled Trial for HyBryte(TM) With the European Medicines Agency

PR Newswire April 3, 2024

Soligenix Announces Recent Accomplishments and Year End 2023 Financial Results

PR Newswire March 15, 2024

Soligenix Announces Formation of Behçet's Disease Medical Advisory Board

PR Newswire February 8, 2024

Soligenix and Mobilicom Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV

Accesswire January 26, 2024

Soligenix to Present at The Microcap Conference

PR Newswire January 25, 2024

FDA Grants Soligenix "Fast Track" Designation for Dusquetide in the Treatment of Oral Lesions of Behçet's Disease

PR Newswire January 8, 2024
View More News ››

Opinion & Analysis (NDAQ:SNGX)

'Data Readouts Approaching in Two Pivotal Trials' for Biopharma Targeting Unmet Needs

Streetwise Reports August 22, 2019

NIH Selects Biopharma's Lead Asset for Commercialization Accelerator Program

Streetwise Reports September 27, 2018

Soligenix's diversified pipeline advances on all fronts

The Life Sciences Report August 31, 2016

VIDEO: Focused on Rare Disease Therapies

BTV-Business Television June 28, 2016

Soligenix develops defenses against bioterrorism SNGX

The Life Sciences Report June 15, 2016

Soligenix fosters potent pipeline of orphan disease compounds in areas of unmet medical need

The Life Sciences Report April 27, 2016
View More Opinion ››

Bullboard Posts (NDAQ:SNGX)

SGNX.....Now tell me....How did it go for all the Chasers

Now trading at 48 cents in AH I tried to warn you this a.m 10 mins after the opening bell ; )
Iseneschal - 7 days ago

RE:SNGX.....in PB mode ...better hold L.O.D or else

Crash ....Booom....Bang....Oh u say the sky is falling? Nope ...just this Beotch....N.L.O.D
Iseneschal - 8 days ago

Soligenix Granted Orphan Drug Designation for the Prevention

Breaking News: $SNGX Soligenix Granted Orphan Drug Designation for the Prevention and Post-Exposure Prophylaxis Against Marburg...
whytestocks - 8 days ago

SNGX.....in PB mode ...better hold L.O.D or else

Has to hold ~ $0.62 and rally
Iseneschal - 8 days ago

FDA Grants Soligenix Orphan Drug Designation for the Prevent

Breaking News: $SNGX FDA Grants Soligenix Orphan Drug Designation for the Prevention and Post-Exposure Prophylaxis Against Marburg...
whytestocks - 8 days ago

SNGX...another Orphan Drug grant by FDA? Yep

And this waiting for all the Chasers...... XBRL Viewer (sec.gov) How do you spell ....MONEY RAISE
Iseneschal - 8 days ago
View more Bullboard ››

i3 Energy Plc.

i3 Energy Plc.

i3 Energy is an oil and gas Company with a low cost, diversified, growing production base in Canada's most prolific ...
View More »